| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2718622 | The American Journal of Medicine | 2013 | 9 Pages |
Abstract
Our analysis of a large international registry demonstrates that nonadherence with evidence-based secondary prevention therapies in patients with established atherothrombosis is associated with a significant increase in long-term adverse events, including mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dharam J. MD, SM, MRCP, Ph. Gabriel MD, Christopher P. MD, Kim A. MD, Sidney C. MD, Elaine PhD, Shinya MD, E. Magnus MD, Deepak L. MD, MPH,